Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Goodwill & Intangibles (2021 - 2025)

Indivior Pharmaceuticals (INDV) has 3 years of Goodwill & Intangibles data on record, last reported at $2.0 million in Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 66.67% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, down 66.67%, while the annual FY2025 figure was $2.0 million, 66.67% down from the prior year.
  • Goodwill & Intangibles reached $2.0 million in Q4 2025 per INDV's latest filing, roughly flat from $2.0 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $82.0 million in Q4 2021 and bottomed at $2.0 million in Q1 2024.
  • Average Goodwill & Intangibles over 3 years is $15.4 million, with a median of $6.0 million recorded in 2024.
  • The widest YoY moves for Goodwill & Intangibles: up 250.0% in 2025, down 66.67% in 2025.
  • A 3-year view of Goodwill & Intangibles shows it stood at $82.0 million in 2021, then tumbled by 92.68% to $6.0 million in 2024, then tumbled by 66.67% to $2.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill & Intangibles were $2.0 million in Q4 2025, $2.0 million in Q3 2025, and $7.0 million in Q2 2025.